Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MS023
i
Other names:
MS023
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
McGill University, University of Montreal
Drug class:
PRMT1 inhibitor
Related drugs:
‹
GSK3368715 (0)
PRMT1 inhibitor (0)
GSK3368715 (0)
PRMT1 inhibitor (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MTAP negative
Non Small Cell Lung Cancer
MTAP negative
Non Small Cell Lung Cancer
talazoparib + MS023
Sensitive: D – Preclinical
talazoparib + MS023
Sensitive
:
D
talazoparib + MS023
Sensitive: D – Preclinical
talazoparib + MS023
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login